Gf Fund Management Co. Ltd. Tarsus Pharmaceuticals, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 978 shares of TARS stock, worth $39,002. This represents 0.0% of its overall portfolio holdings.
Number of Shares
978
Previous 803
21.79%
Holding current value
$39,002
Previous $44.5 Million
13.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TARS
# of Institutions
201Shares Held
44.5MCall Options Held
19.9KPut Options Held
7.6K-
Rtw Investments, LP New York, NY3.32MShares$132 Million2.79% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$130 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.61MShares$104 Million6.87% of portfolio
-
Jennison Associates LLC2.49MShares$99.4 Million0.09% of portfolio
-
Tang Capital Management LLC San Diego, CA2.45MShares$97.9 Million8.19% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.06B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...